Dr. McClintock and Colleagues Reply
J Clin Psychiatry 2008;69(10):1662-1663 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: We appreciate the comments made by Dr. Swartz on our
recent report of electroconvulsive therapy (ECT) in the treatment
of atypical depression. We agree that our study was limited
due to the lack of a placebo control group and to the use of
the 24-item Hamilton Rating Scale for Depression (HAM-D-
24). Without a placebo control, we cannot be certain that ECT
was beneficial in treating severely depressed patients with
atypical features in the acute phase (i.e., spontaneous improvement
could have occurred).